Viewing Study NCT04032704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2026-03-27 @ 8:37 AM
Study NCT ID: NCT04032704
Status: TERMINATED
Last Update Posted: 2025-03-10
First Post: 2019-07-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors
Sponsor: Seagen Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Small Cell Lung Cancer View
None Non-small Cell Lung Cancer, Squamous View
None Non-small Cell Lung Cancer, Non-squamous View
None Head and Neck Squamous Cell Carcinoma View
None Esophageal Squamous Cell Carcinoma View
None Gastric Adenocarcinoma View
None Gastroesophageal Junction Adenocarcinoma View
None Prostate Cancer View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SCLC View
None NSCLC-squamous View
None NSCLC-nonsquamous View
None HNSCC View
None GEJ adenocarcinoma View
None Seattle Genetics View